AN2 Therapeutics
existing cash funds value driving milestones cash cash equivalents and investments as of an therapeutics | AN2 Therapeutics
Company
Deck Type
Sector
Industry
Deck date
August 2022
Slide
22 of 25
Related slides by other companies
Electronic Arts
Results
February 2022
growth topline to cash net revenue net bookings operating cash flow | Electronic Arts
Aeglea BioTherapeutics
Investor Presentation
October 2023
cash and anticipated milestones | Aeglea BioTherapeutics
Electronic Arts
Results
November 2023
cash flow selected data operating cash flow capital expenditures free cash flow investing cash flow financing cash flow | Electronic Arts
Electronic Arts
Results
November 2021
growth topline to cash cee other a net revenue net bookings operating cash flow | Electronic Arts
Other recent decks by AN2 Therapeutics
See all presentations (2 decks)
IPO
March 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io